This 2019 report from the Medicaid and CHIP Payment and Access Commission reviews covers Medicaid policies related to medication assisted treatment (MAT) for opioid use disorder.
Policymakers & Community Leaders
Search Results for: (37 results)
Policymakers & Community Leaders
Using Medicaid to Advance Evidence-based Treatment of Substance Use Disorders: A Toolkit for State Medicaid Leaders
Source: Manatt
This toolkit by Manatt provides promising strategies state Medicaid agencies can adopt to address the substance use disorder (SUD) and opioid use disorder (OUD) crisis in their states.
Policymakers & Community Leaders
Payers & Providers
State Medicaid Strategies to Promote Early Identification and Treatment of Pregnant Women with Substance Use Disorder
Source: National Academy for State Health Policy
This policy brief from the National Academy for State Health Policy reviews Medicaid strategies for identifying and caring for pregnant women with substance use disorders. The report provides a high-level overview of programs operational in 5 states: Connecticut, Florida, Tennessee, Montana, and Vermont.
Policymakers & Community Leaders
Payers & Providers
Evidence-Based Practices and Medication Assisted Treatment for Opioid Use Disorder, Virginia Department of Medical Assistance Services
This 2019 bulletin describes evidence-based practices for providing medication assisted treatment (MAT) for individuals with opioid use disorder and coverage of these treatment by Virginia’s Medicaid program.
Policymakers & Community Leaders
Payers & Providers
State Variations in Medicaid Prescriptions for Opioid Use Disorder from 2011 to 2018
Source: L. Clemons-Cope et. al.
This 2019 report from the Urban Institute analyzed Medicaid State Drug Utilization Data to assess variation in buprenorphine prescriptions across state Medicaid programs between 2011 and 2018.
Policymakers & Community Leaders
Payers & Providers
State Guidance for the New Limited Exception to the IMD Exclusion for Certain Pregnant and Postpartum Women (SUPPORT Act): Help for Moms and Babies
Source: Centers for Medicare and Medicaid Services
The 2018 SUPPORT Act passed by Congress directed the Centers for Medicare and Medicaid Services to create a exception to the institution for mental disease (IMD) exclusion for certain pregnant and postpartum women. The IMD exclusion forbids the expenditure of federal funding on services provided in facilities with
Policymakers & Community Leaders
Payers & Providers
State Guidance for Implementation of the Treatment for Infants with Neonatal Abstinence Syndrome in Residential Pediatric Recovery Centers (SUPPORT Act)
Source: Centers for Medicare and Medicaid Services
The 2018 SUPPORT Act passed by Congress directed the Centers for Medicare and Medicaid Services to create a new provider type in Medicaid of “residential pediatric recovery centers” (RPRCs) which treat infants with neonatal opiate withdrawal/neonatal abstinence syndrome. This letter provides guidance for states wishing to add RPRCs as provider types eligible for reimbursement through Medicaid.
Policymakers & Community Leaders
Report to the President and Congress: Section 1018 Action Plan for Technical Assistance and Support for Innovative State Strategies to Provide Housing-related Supports to Individuals with Substance Use Disorder Under Medicaid
Source: U.S. Department of Health and Human Services
This 2019 report to the President and Congress describes how the U.S. Department of Health and Human Services plans to assist states in providing housing-related supports to individuals with substance use disorders in Medicaid as instructed by the 2018 SUPPORT Act. The report describes forthcoming initiatives from
Policymakers & Community Leaders
Payers & Providers
Patients & Caregivers
State Strategies for Expanding Access to Opioid Use Disorder Medications
Source: Center for Evidence-based Policy
This 2 page guide summarizes effective strategies to increase patient access to medication assisted treatment for opioid use disorder (OUD). Strategies for state program administrators, clinicians and health systems, and individuals with OUD are presented.
Payers & Providers
The Impact of 42 CFR Part 2 on Care Coordination by Health Plans for Members with Substance Use Disorders
Source: Association for Community Affiliated Plans
Researchers and health care providers increasingly realize the importance of coordinating a patient’s behavioral and medical health care. Federal regulations under 42 CFR Part 2 require that providers obtain patient consent before sharing information about substance use disorder treatment. This report from the Association for Community Health Plans describes the challenges insurers